TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 273 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,858 | -11.6% | 2,124 | -10.2% | 0.00% | 0.0% |
| Q2 2023 | $37,170 | +78985.1% | 2,366 | -16.6% | 0.00% | 0.0% |
| Q1 2023 | $47 | +30.6% | 2,836 | +22.8% | 0.00% | 0.0% |
| Q4 2022 | $36 | -100.0% | 2,309 | -80.7% | 0.00% | -75.0% |
| Q2 2022 | $168,000 | +211.1% | 11,938 | +218.0% | 0.00% | +300.0% |
| Q1 2022 | $54,000 | -68.4% | 3,754 | -63.1% | 0.00% | -75.0% |
| Q2 2021 | $171,000 | -61.0% | 10,165 | -57.6% | 0.00% | -42.9% |
| Q1 2021 | $438,000 | +10850.0% | 23,975 | +11887.5% | 0.01% | – |
| Q4 2020 | $4,000 | -66.7% | 200 | -69.2% | 0.00% | – |
| Q3 2020 | $12,000 | -72.7% | 650 | -73.4% | 0.00% | -100.0% |
| Q2 2020 | $44,000 | – | 2,442 | +16180.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 15 | -99.9% | 0.00% | -100.0% |
| Q4 2019 | $205,000 | +502.9% | 10,411 | +448.5% | 0.02% | +750.0% |
| Q2 2019 | $34,000 | +3300.0% | 1,898 | +4645.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |